Testing effectiveness (Phase 2)Ended earlyNCT04553406
What this trial is testing
Safety, Tolerability, Pharmacokinetics and Efficacy of SPR720 for the Treatment of Patients With Mycobacterium Avium Complex (MAC) Pulmonary Disease
Who this might be right for
Mycobacterium Avium ComplexNon-tuberculous Mycobacterium Pulmonary Disease
Spero Therapeutics 2